During the most recent trading session, Zions Bancorporation (NASDAQ:ZION) shares traded -1.55%. Tracking the stock price in relation to moving averages may provide enhanced perspective on stock performance. After a recent look, the stock has been seen trading $0.13 off of the 50-day moving average of $40.57 and $-1.10 separated from the 200-day moving average of $41.80. Taking a further look from a different perspective, the stock has been recently recorded -15.79% off of the 52-week high of 48.33 and +76.80% apart from the 52-week low of 23.02. Monitoring stock price activity relative to moving averages and the highs and lows for the past year might help with future stock price value assessment.
Price Target in Focus
While monitoring stock technicals is important, most investors are more concerned with where the stock might be going now. Equity research analysts have provided views on where they believe the stock will be trading in the future. According to Thomson Reuters, sell-side analysts are projecting a consensus target price of $46.04 on company shares. This is a near-term estimate for the next 12-18 months.
Currently, Zions Bancorporation has a price to earnings ratio of 18.33. Analysts and investors may also opt to evaluate a company's PEG or price to earnings growth ratio. The stock currently has a PEG Ratio of 1.10.
Zimmer Biomet Holdings Inc (NYSE:ZBH) shares have a current ABR (average broker recommendation) of 1.93. This recommendation is offered by Zacks Research. The rating lands on a sliding numerical scale from 1 to 5. A recommendation of 5 would indicate a Strong Sell, and a 1 would signify a Strong Buy. The mean rating may help provide a general sense of analyst sentiment on company shares.
Sell-side analysts taken into consideration by Zacks have also provided price target estimates on shares of Zimmer Biomet Holdings Inc (NYSE:ZBH). The highest current target is $153. The lowest price target out of the polled analysts is presently $120. The consensus target price is currently noted at $134.812. Analysts may employ various techniques to help predict future stock price levels.
On the earnings front, Zimmer Biomet Holdings Inc (NYSE:ZBH) is expected to post quarterly earnings per share of $2.1. This is the current consensus figure provided by Zacks. Investors and analysts will be looking for the company to next post earnings on or around 2017-07-27. Zimmer Biomet Holdings Inc (NYSE:ZBH) most recently reported quarterly EPS of $2.13 for the quarter ending 2017-03-31. The gap between the actual and the projected estimate leading up to earnings created a surprise factor of 0.95%.